Marzac, Christophe
Inserm · Université Paris-Saclay · Institut Gustave Roussy · Cellules souches hématopoïétiques et développement des hémopathies myéloïdes · Fondation Gustave Roussy
3 papers on CoChatORCID 0000-0001-5065-0376
Most cited papers
- Verified
Mutation in TET2 in Myeloid Cancers
Delhommeau, F., Dupont, S., Valle, V. D., James, C., Trannoy, S., Massé, A., Kosmider, O., Le Couedic, J.-P., Robert, F., Alberdi, A., et al. (2009) · New England Journal of Medicine
Acute Myeloid Leukemia ResearchMyeloproliferative Neoplasms: Diagnosis and Treatment
Cited by 1,776
- Verified
Single-cell multi-omics identifies chronic inflammation as a driver of TP53-mutant leukemic evolution
Rodriguez-Meira, A., Norfo, R., Wen, S., Chédeville, A. L., Rahman, H., O’Sullivan, J., Wang, G., Louka, E., Kretzschmar, W. W., Paterson, A., et al. (2023) · Nature Genetics
Acute Myeloid Leukemia ResearchCancer Genomics and Diagnostics
Cited by 158
- Verified
Inferring the dynamics of mutated hematopoietic stem and progenitor cells induced by IFNα in myeloproliferative neoplasms
Mosca, M., Hermange, G., Tisserand, A., Noble, R., Marzac, C., Marty, C., Le Sueur, C., Campario, H., Vertenoeil, G., El-Khoury, M., et al. (2021) · Blood
Myeloproliferative Neoplasms: Diagnosis and TreatmentAcute Myeloid Leukemia Research
Cited by 57
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free